Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 16:5:355.
doi: 10.3389/fgene.2014.00355. eCollection 2014.

The fragile X syndrome-autism comorbidity: what do we really know?

Leonard Abbeduto  1 , Andrea McDuffie  1 , Angela John Thurman  1
Affiliations

The fragile X syndrome-autism comorbidity: what do we really know?

Leonard Abbeduto et al. Front Genet. .

Abstract

Autism spectrum disorder (ASD) is a common comorbid condition in people with fragile X syndrome (FXS). It has been assumed that ASD symptoms reflect the same underlying psychological and neurobiological impairments in both FXS and non-syndromic ASD, which has led to the claim that targeted pharmaceutical treatments that are efficacious for core symptoms of FXS are likely to be beneficial for non-syndromic ASD as well. In contrast, we present evidence from a variety of sources suggesting that there are important differences in ASD symptoms, behavioral and psychiatric correlates, and developmental trajectories between individuals with comorbid FXS and ASD and those with non-syndromic ASD. We also present evidence suggesting that social impairments may not distinguish individuals with FXS with and without ASD. Finally, we present data that demonstrate that the neurobiological substrates of the behavioral impairments, including those reflecting core ASD symptoms, are different in FXS and non-syndromic ASD. Together, these data suggest that there are clinically important differences between FXS and non-syndromic ASD that are masked by reliance on the categorical diagnosis of ASD. We argue for use of a symptom-based approach in future research, including studies designed to evaluate treatment efficacy.

Keywords: autism spectrum disorder; comorbid conditions; fragile X syndrome; language and communication impairments; psychiatric conditions.

PubMed Disclaimer

References

    1. Abbeduto L., Brady N., Kover S. T. (2007). Language development and fragile X syndrome: profiles, syndrome-specificity, and within-syndrome differences. Ment. Retard. Dev. Disabil. Res. Rev. 13, 36–46. 10.1002/mrdd.20142 - DOI - PMC - PubMed
    1. Bailey D. B., Hatton D. D., Mesibov G., Ament N., Skinner M. (2000). Early development, temperament, and functional impairment in autism and fragile X syndrome. J. Autism Dev. Disord. 30, 49–59. 10.1023/A:1005412111706 - DOI - PubMed
    1. Bailey D. B., Jr., Hatton D. D., Skinner M., Mesibov G. (2001). Autistic behavior, FMR1 protein, and developmental trajectories in young males with fragile X syndrome. J. Autism Dev. Disord. 31, 165–174. 10.1023/A:1010747131386 - DOI - PubMed
    1. Bailey D. B., Jr., Raspa M., Olmsted M., Holiday D. B. (2008). Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am. J. Med. Genet. A 146A, 2060–2069. 10.1002/ajmg.a.32439 - DOI - PubMed
    1. Baio J. (2012). Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ. 61, 1–19 - PubMed